Drug Profile
Aspirin controlled release - New Haven Pharmaceuticals
Alternative Names: Aspirin slow-release - New Haven Pharmaceuticals; Durlaza; NHP-554CLatest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator New Haven Pharmaceuticals
- Class Analgesics; Antineoplastics; Antiplatelets; Antipyretics; Antirheumatics; Heart failure therapies; Nonsteroidal anti-inflammatories; Salicylic acids; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide stimulants; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cardiovascular disorders; Stroke